Cholinergic Muscarinic Antagonist [EPC]

39246 reported adverse events

Drugs of this class: OXYBUTYNIN ACONITUM NAPELLUS, ADRENALINUM, AGARICUS MUSCARIUS, APIS MELLIFICA, ATROPINUM, CAMPHORA, CANTHARIS, CAUSTICUM, CEREBRUM SUIS, CHAMOMILLA, CICUTA VIROSA, CUPRUM METALLICUM, HOMARUS, HYOSCYAMUS NIGER, HYPOPHYSIS SUIS, LAC CANINUM, MOSCHUS, STRAMONIUM, TARENTULA HISPANA, VERATRUM ALBUM APIS MELLIFICA, CANTHARIS, CHAMOMILLA, ADRENALINUM, CEREBRUM SUIS, HYPOPHYSIS SUIS, ACONITUM NAPELLUS, AGARICUS MUSCARIUS, ATROPINUM, CAUSTICUM, CICUTA VIROSA, CUPRUM METALLICUM, HYOSCYAMUS NIGER, LAC CANINUM, MOSCHUS, STRAMONIUM, TARENTULA HISPANA, VERATRUM ALBUM, HOMARUS, CAMPHORA ATROPINE ATROPINE INJECTION, 2 MG ATROPINE SULFATE INJECTION USP, 0.5 MG/0.7 ML ATROPINE SULFATE INJECTION USP, 1 MG/0.7 ML LOW BACK PAIN DROPS NERVOUSE SYSTEM AID

These side effects are most commonly reported by patients taking drugs of the Cholinergic Muscarinic Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 4640
1 FATIGUE 2139
2 OFF LABEL USE 1902
3 FALL 1788
4 NAUSEA 1782
5 DIARRHOEA 1725
6 PAIN 1523
7 DEATH 1506
8 DIZZINESS 1367
9 HEADACHE 1270
See all common reactions for Cholinergic Muscarinic Antagonist [EPC]

Drugs of the Cholinergic Muscarinic Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTICHOLINERGIC SYNDROME 127 0.0797
1 APPLICATION SITE ERYTHEMA 932 0.0355
2 APPLICATION SITE PRURITUS 619 0.0273
3 APPLICATION SITE RASH 351 0.0255
4 PRODUCT ADHESION ISSUE 844 0.0236
5 DRUG ADMINISTERED AT INAPPROPRIATE SITE 194 0.0184
6 APPLICATION SITE IRRITATION 206 0.0165
7 BLADDER DISORDER 133 0.0134
8 URINARY INCONTINENCE 376 0.0127
9 MACULAR DEGENERATION 143 0.0120
See all enriched reactions for Cholinergic Muscarinic Antagonist [EPC]